Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SALVAGE Trial (Safety And cLinical Value of AutoloGous rEinfusion)

NCT: NCT07712666 · NOT_YET_RECRUITING

NCT IDNCT07712666
StatusNOT_YET_RECRUITING
Start Date2026-11-01
Completion2029-08-01
SponsorMayo Clinic (OTHER)
First posted
Last updated

Brief Summary

The investigator hypothesizes intraoperative salvaged red blood cells are a poor substitute for allogenic packed red blood cell transfusions. In addition to providing inadequate resuscitation, salvaged red blood cells can increase the rate of complications, including postoperative electrolyte abnormalities, thrombocytopenia, anemia, and coagulopathy.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑